J.P. Morgan Notebook: Thursday, January 16
This article was originally published in The Pink Sheet Daily
Executive Summary
News and notes from the fourth and final day of the 2014 J.P. Morgan Healthcare Conference, including highlights from Furiex Pharmaceuticals’ late-stage pipeline, GSK’s latest DPU, newly public Intrexon, and angel-backed KemPharm.